AMPIO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ampio Pharmaceuticals, Inc.
NEW YORK, Nov. 18, 2013 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) in connection with possible claims of breaches of fiduciary duty.
To get more information, click here: http://zlk.9nl.com/ampio-pharmaceuticals-ampe/. There is no cost or obligation to you.
If you own common stock in Ampio Pharmaceuticals, Inc. and wish to obtain additional information, please contact Eduard Korsinsky, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/ampio-pharmaceuticals-ampe/.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
SOURCE Levi & Korsinsky, LLP
More by this Source
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against GLOBAL GEOPHYSICAL SERVICES, INC. and Its Board of Directors and a Lead Plaintiff Deadline of May 19, 2014 -- GGS
Apr 11, 2014, 15:31 ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against UTi Worldwide Inc. and Its Board of Directors and a Lead Plaintiff Deadline of May 16, 2014 -- UTIW
Apr 11, 2014, 14:57 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.